medline.ch Urologie-Nephrologie

	Consolidative therapy for PSMA-avid lesions after 3 cycles of apalutamide plus androgen deprivation in metastatic hormone-sensitive prostate cancer: A prospective phase 2 single-arm trial. Eur J Nucl Med Mol Imaging Pan J, Wang B, Zhu B, Gan H, Hu X, Liu X, Li X, Wu J, Wang H, Zhang Q, Liu C, Song S, Ma X, Ye D, Zhu Y. PMID: 42252348 [PubMed - as supplied by publisher]
	ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiome modulations After kidney transplantation (ENIGMA): study protocol of a prospective longitudinal trial. BMJ Open Barbé A, Boland L, Kanaan N, Darius T, Buemi A, France Y, Ronsyn MA, Rahal S, Lingurski M, Van Bambeke F, Bindels LB, Haufroid V, Devresse A, Elens L. PMID: 42252139 [PubMed - in process]
	Clinical Efficacy of Vitamin D Supplements for the Treatment of Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Hemodial Int Wanyan X, Xu J. PMID: 42252089 [PubMed - as supplied by publisher]
	Evaluation of the bioassay for detecting early endothelial activation using microvascular cultures in renal transplant recipients. Transpl Immunol Jiang X, Li M, Fang J, Qin X, Wang Z, Yang M, Qiao L, Liu X, Liang S, Wu H, Zhao N, Chen L, Meng Q, Shi QS, CLS(ASCP). PMID: 42252029 [PubMed - as supplied by publisher]
	Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study". Am J Transplant Reuter S, Lachmann N, Arnol M. PMID: 42252027 [PubMed - as supplied by publisher]
	Cognitive impairment in chronic kidney disease: pathophysiological mechanisms and potential modulatory effects of resveratrol. J Ren Nutr Aguilera P, Alquisiras-Burgos I, Franco-Pérez J. PMID: 42251988 [PubMed - as supplied by publisher]
	Association between HbA1c variability and disease prognosis in chronic kidney disease patients: a systematic review and meta-analysis. Diabetes Res Clin Pract Abudoureheman W, Zhang F, Huang L, Bai Y, Wang Y, Su L, Zhou R, Sun Q. PMID: 42251946 [PubMed - as supplied by publisher]
	Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer. Discov Oncol Feng W, He W. PMID: 42251607 [PubMed - as supplied by publisher]
	Cell-Derived Nanomaterials for Acute Kidney Injury: A Pathophysiology-Driven Framework for Precision Delivery and Multimodal Therapy. J Drug Target Zheng Y, Li Q, Liu Y, Huang Q, Peng Y, Li X, Zhang R, Li R, Zhou X, Lou J. PMID: 42251524 [PubMed - as supplied by publisher]
	Association of the CHG Index with the onset, progression, and prognosis of cardiovascular-kidney-metabolic syndrome: findings from two large prospective cohorts. Diabetol Metab Syndr Zhao Z, Bai Y, Ma C, Wang T, Zhao L, Zhao X, Li Q, Ding Y, Zhang Y, Lin L, Wang W, Han J, Zeng Y. PMID: 42251380 [PubMed - as supplied by publisher]
	Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer. Cancer Cell Int Zhao H, Li K, Xu H, Liao J, Zhuo C, Wang Q, Liu X, Kang Z, Zhu B, Lai X, Zhu S, Zhang Y, Zeng J. PMID: 42251369 [PubMed - as supplied by publisher]
	A retrospective study of CKDu progression in Sri Lanka: analysis of kidney biopsies and association with risk factors. BMC Nephrol Hewapathiranage S, Pushpakumara N, Sonnadara T, Weerakoon T, Erandika N, Adhikari S, Angeloni M, Ferrazzi F, Amann K, Wazil AWM, Chandrajith R, Ratnatunga N, Wijethunge S, Enghard P, Daniel C, Nanayakkara N. PMID: 42251320 [PubMed - as supplied by publisher]
	Diagnostic value of PSA-based markers in prostate cancer: a retrospective analysis stratified by body mass index. BMC Urol Yang T, Zhang Q, Liu Z, Tian J, Hu X, Lv Z. PMID: 42251295 [PubMed - as supplied by publisher]
	Environmental exposures and pediatric kidney health. Pediatr Res Gerber A, Cacanindin Z, Scialla J, Kamath N. PMID: 42251176 [PubMed - as supplied by publisher]
	Relationship between medication class and ambulatory blood pressure profile in the chronic renal insufficiency cohort (CRIC) study. J Hum Hypertens Pasricha SV, Cohen DL, Shulman R, Byfield R, Cohen JB, CRIC Study Investigators. PMID: 42251167 [PubMed - as supplied by publisher]
	Plasma exosomal microRNAs as early predictors of subclinical acute kidney injury in septic patients undergoing major non-cardiac surgery: a prospective observational cohort study. Sci Rep Mohammadi A, Bakhtiyari Z, Mokabber N, Fattahi V. PMID: 42251093 [PubMed - as supplied by publisher]
	"Why children with anorectal malformations need urological evaluation: Insights from a retrospective study". J Pediatr Urol Isabel PD, Isabel CB, Cristina MR, Laura DM, María José MJ, Rocío GC, Rosa RR. PMID: 42250957 [PubMed - as supplied by publisher]
	Fenchone and Cinnamyl Acetate Attenuate L-NAME-Induced Hypertension via Modulation of Vascular Dysfunction, Oxidative Stress, and Renal Injury: An Integrated Network Pharmacology, Molecular Docking, and ADMET Study. Eur J Pharmacol Zeeshan A, Malik A, Ali M, Qaisar MN, Ahmad I, Wajid M, Khalid A, Muhammad G. PMID: 42250790 [PubMed - as supplied by publisher]
	Urinary Exosomal ATF3 as a non-invasive biomarker for early detection of acute kidney injury. Clin Chim Acta Arya DK, Verma A, Mishra R, Mueller E, Verma N. PMID: 42250676 [PubMed - as supplied by publisher]
	Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer. Ann Oncol Parker CTA, Huang HC, Grist E, Mendes L, Yamashita R, Croucher D, Sachdeva A, Murphy L, Liu VYT, Vidal SS, Todorovic T, Lall S, Goncalves M, Thakali S, Wingate A, Zakka L, Wetterskog D, Nowakowska K, Amos CL, STAMPEDE Collaborators, Berney DM, Tran PT, Spratt DE, Sydes MR, Brown LC, Zhao SG, Nguyen P, Clarke NW, Sweeney CJ, Stewart EL, Parmar MKB, Esteva A, James ND, Attard G. PMID: 42250604 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 473439

Seite 1 von 23672

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung